Read the following news article, which raises concerns about FDA investigation of generic drug manufacturers: New York Times: Katherine Eban, Americans Need Generic Drugs. But Can They Trust Them? https://www.nytimes.com/2019/05/11/opinion/sunday/generic-drugs-safety.html Answer the following questions: (1) What problems do you see with the FDAs current regulatory process with respect to generic drugs? (2) How should these problems be addressed? How could investigation and enforcement be improved? What types of interventions do you think would be most effective?
